Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2

medRxiv(2021)10.1101/2021.09.17.21263528Source: DataRank Database

Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2 is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: greenTopics (38)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Natalie Bruiners ORCID,Hridesh Mishra ORCID,Pankaj Kumar Mishra ORCID,Deborah McCloskey,Alberta Onyuka

Live enrichment

PubMed:34580675 OpenAlex:https://openalex.org/W3200123672

National Institutes of Health

Grant: 1R01HL149450-01A1

Foam cells as drug targets in tuberculosis

National Institutes of Health

Grant: 1R61HD105619-01

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)

National Institutes of Health

Grant: 5UL1TR003017-03

New Jersey Alliance for Clinical Translational Science: NJ ACTS

National Institutes of Health

Grant: 3R01AI158911-02S1

Cohort and biomarkers for COVID-19 severity, natural history, and reinfection

National Institutes of Health

Grant: 5U01AI122285-06

Microbial, immune, metabolic perturbations by antibiotics (MIME study)

NHLBI NIH HHS

Grant: R01 HL149450

NIAID NIH HHS

Grant: U01 AI122285

NCATS NIH HHS

Grant: UL1 TR003017

greenLicense: cc-by

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/09/21/2021.09.17.21263528.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.09.17.21263528

repositoryhttps://doi.org/10.1101/2021.09.17.21263528

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34580675

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesImmunotherapy and Immune Responses

Keywords

ImmunogenicityVaccinationImmunologyAntibodyVirologyNeutralizing antibodyPandemicImmune systemMedicineMessenger RNABiologyAntigenCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)GeneInternal medicineAd26.COV2.SCOVID-19 VaccinesAd26COVS1SARS-CoV-2RCOVID-19Neutralizing antibodiesAntibodies, ViralArticleImmunity, HumoralmRNA-1273CorrespondenceHumansBNT162b2RNA, MessengermRNA VaccinesAntibody bindingAntigen-specific B cells

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being